Tackling the Alzheimer’s 99.6% problem

Tackling the Alzheimer’s 99.6% problem

Presented by: Jan Turner and Chris Ward

Watch our webinar to learn how we’re tackling the 99.6% failure rate of Alzheimer’s drug development. Hear from Axol Product Manager, Jan Turner, and StrataStem Co-founder/CSO Chris Ward, about how we’re turning patient samples into powerful “clinical trial in a dish” models to accelerate drug discovery and drive better, safer therapies for Alzheimer’s patients worldwide.

You can expect Jan and Chris to cover:

 

• The growing need for new therapies to tackle Alzheimer’s Disease
  
• StrataStem’s patient donation project for a diverse source of human stem cells
  
• How we’re looking to collaborate with biopharma to build and validate our Alzheimer’s Disease “Clinical Trial in a Dish”.
  
• How we’re tackling the “99.6%” problem using human iPSCs